(Gln⁵³)-Connexin 37 (51-58) (human, mouse, rat) |
| Catalog No.GA20185 |
MUT 1, a tumor-associated antigen peptide originally isolated from the mouse Lewis lung carcinoma, appears to be a fragment of the gap junction protein connexin 37, mutated at position 54. MUT 1 induces effective antitumor cytotoxic T lymphocytes and mediates protection against metastasis, as well as rejection of established metastasis. This is the first description of peptide vaccine efficacity in treatment of residual tumors.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 155893-22-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MUT 1, a tumor-associated antigen peptide originally isolated from the mouse Lewis lung carcinoma, appears to be a fragment of the gap junction protein connexin 37, mutated at position 54. MUT 1 induces effective antitumor cytotoxic T lymphocytes and m
Average Rating: 5 (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *